Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pancreatic biomarkers: could they be the answer?

World journal of gastroenterology - 28 Jun 2014

Lamarca Angela, Feliu Jaime

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDA) is known for its poor prognosis. Most of the patients are diagnosed with advanced stages, when no curative treatment is available. Currently, despite extensive clinical research on PDA, the median overall survival remains short. Diagnosis delay and primary chemo-resistance due to its intrinsic biological nature may explain the challenges to improve our results. Our knowledge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Pancreatic Ductal
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pancreatic Neoplasms

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24976720
DOI: 10.3748/wjg.v20.i24.7819
PMCID: PMC4069311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pancreatic biomarkers: could they be the answer?PMID 24976720Read ↗

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read ↗

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.Semantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review.Semantic proximity Read ↗

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.Semantic proximity Read ↗

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside TranslationSemantic proximity Read ↗

A Young Scientist's Guide to PDAC: Past, Present, and FutureSemantic proximity Read ↗

Cellular and molecular aspects of pancreatic cancer.Semantic proximity Read ↗

Molecular Pathogenesis of Pancreatic Cancer.Semantic proximity Read ↗

Molecular biology of pancreatic cancer.Semantic proximity Read ↗

Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer.Semantic proximity Read ↗

Molecular markers of pancreatic cancer: development and clinical relevanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.